The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Mon, 28th Sep 2020 15:53

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

SSE PLC - energy firm - Non-Executive Director Crawford Gilles to step down with effect on Wednesday after five years in the role since 2015. SSE's board to compromise of chair, three executive directors and seven non-executive directors.

----------

Tracsis PLC - traffic data & transportation services - Appoints Andrew Kelly as chief financial officer with effect on February 1, 2021. Will replace Max Cawthra, who is stepping down from role after 10 years since 2011. Kelly is currently vice president of Finance & IT at Vitec Production Solutions, a division of photography & video products maker Vitec Group PLC.

----------

Bank of Cyprus Holdings PLC - banking - First Deputy Chief Executive Officer Chris Patsalides to step down with effect on October 31, after a 25-year tenure with the group. In addition, has appointed Constantine Iordanou as non-executive director and Executive Director of Finance Eliza Livadiotou to board as executive member. Both appointments require approval from European Central Bank.

----------

ULS Technology PLC - Oxfordshire-based conveyancing software provider - Chief Executive Officer Steve Goodall has stepped down from role with immediate effect to pursue other interests, after three years since 2017. Following an extensive search, the group has found a successor with extensive performance, but has not disclosed who the successor is.

----------

Henderson European Focus Trust PLC - investment trust - Appoints Senior Independent Director Vicky Hastings as interim chair, following the stepping down of Chair Robert Jeens with effect on Friday last week, for personal reasons, after ten months in the role since December 2019.

----------

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - Appoints Chief Executive Officer Kirill Golovanov as interim chair with immediate effect, following the death of Executive Chair Mikhail Mogutov on Thursday last week, after 12 years in the role.

----------

Vectura Group PLC - London-based drug delivery products firm - Non-Executive Director Anne Whitaker to step down with effect on Wednesday, due to potential conflicts that could arise in the future, from her role as chief executive officer at Aerami Therapeutics, which specialises in the treatment of severe respiratory and chronic diseases.

----------

Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical company focused on oncology and rare diseases - Appoints Brian Schwartz and Jeremy Bender as non-executive directors with effect on October 1. In addition, Non-Executive Director Paul Blackburn to step down after five years since 2015.

----------

British Smaller Companies VCT2 PLC - UK-focused venture capital trust - Appoints Barbara Anderson with effect on October 1. Also announced the resignation of Robert Pettigrew with effect at the end of 2020 after 20 years in the role.

----------

Blue Prism Group PLC - Warrington, England-based robotic process automation - Appoints Rachel Mooney as non-executive director with immediate effect.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Jan 2019 12:58

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Read more
5 Dec 2018 14:33

Mereo BioPharma To Acquire US Oncology Firm In All Stock Deal

LONDON (Alliance News) - Mereo BioPharma Group PLC on Wednesday said it will buy US oncology-focused clinical stage biopharmaceutical business OncoMed Pharmaceuticals Inc via a all-stock deal at a

Read more
5 Nov 2018 12:26

Mereo BioPharma Doses First Patient In Phase Two MPH-966 Study

LONDON (Alliance News) - Rare disease pharmaceutical company Mereo Biopharma Group PLC said on Monday it has has dosed its first patient in its Phase 2 clinical study of MPH-966, which is for the

Read more
15 Oct 2018 11:20

Mereo Completes Patient Enrolment In Brittle Bone Disease Drug Trial

LONDON (Alliance News) - Mereo Biopharma Group PLC on Monday said it has completed patient enrolment in its phase 2b clinical study of its drug BPS-804, or Setrusumab, which is being conducted in

Read more
1 Oct 2018 13:15

Mereo BioPharma Completes Positive Revision Of Credit Facility Terms (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday that it completed a revision of the terms of its credit facility with Silicon Valley Bank and Kreos Capital.The revised terms

Read more
8 Aug 2018 12:53

Mereo BioPharma Considering Fundraise As Interim Loss Narrows

LONDON (Alliance News) - Mereo BioPharma Group PLC said Wednesday it continues to make progress on "all fronts" after narrowing its interim loss.For the six months to June 30, the

Read more
14 Jun 2018 14:40

UK Shareholder Meetings Calendar - Next 7 Days

Friday 15 JuneJD Sports Fashion (re acquisition of The Finish Line)MP Evans GroupBaker Steel 18 (re 19

Read more
29 May 2018 12:31

Mereo BioPharma Looks To Broaden Shareholder Base (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Tuesday it placed 50,076 shares at 300 pence each.Following admission to trading of the new shares, which is expected to occur on 1,

Read more
26 Apr 2018 13:36

Mereo BioPharma Halts Listing On Nasdaq Due To Market Conditions (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Thursday it has decided to postpone its proposed listing of American depository shares on the Nasdaq Global Market.Mereo said the

Read more
19 Mar 2018 13:14

Mereo BioPharma Hails Positive BGS-649 Phase II Clinical Trial Data

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday it had received positive top-line data for its phase II clinical trial for hypogonadotropic hypogonadism in said

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
16 Sep 2016 10:15

Mereo Biopharma Progresses Drug Candidates In Maiden Interim Period

Read more
11 Jul 2016 15:07

UK Shareholder Meetings Calendar - Next 7 Days

Read more
30 Jun 2016 08:07

Mereo Biopharma Gets European Approval For Bone Disorder Treatment

Read more
9 Jun 2016 08:36

Mereo Biopharma Shares Up 22% As It Starts Trading On AIM (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.